Radioimmunotherapy of experimental human metastatic melanoma with melanin-binding antibodies and in combination with dacarbazine

Clinical Cancer Research

Volumn 15, Issue 7, 2009, Pages 2373-2379

  Revskaya, Ekaterina ^a   Jongco, Artemio M ^b   Sellers, Rani S ^a   Howell, Robertha C ^a   Koba, Wade ^a   Guimaraes, Allan J ^a   Nosanchuk, Joshua D ^a   Casadevall, Arturo ^a   Dadachova, Ekaterina ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DACARBAZINE; FLUORODEOXYGLUCOSE F 18; IMMUNOGLOBULIN M ANTIBODY; MELANIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 11B11 RE 188; MONOCLONAL ANTIBODY 6D2 RE 188; RHENIUM 188; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CANCER CHEMOTHERAPY; CELL SECRETION; CONTROLLED STUDY; DRUG BINDING; DRUG EFFICACY; DRUG TARGETING; DRUG TOLERABILITY; FEMALE; HUMAN; HUMAN CELL; ISOTOPE LABELING; MELANOMA; METASTASIS; MOUSE; NONHUMAN; NUDE MOUSE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; SINGLE DRUG DOSE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS, ALKYLATING; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; DACARBAZINE; FEMALE; HUMANS; MELANINS; MELANOMA; MICE; MICE, NUDE; NEOPLASM METASTASIS; ORGANOMETALLIC COMPOUNDS; POSITRON-EMISSION TOMOGRAPHY; RADIOIMMUNOTHERAPY; SKIN NEOPLASMS;

EID: 65249171980     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-08-2376     Document Type: Article

References (20)

1. Safa MM, Foon KA. Adjuvant immunotherapy for melanoma and colorectal cancers. Semin Oncol 2001;28:68-92.
2. Sun W, Schuchter LM. Metastatic melanoma. Curr Treat Options Oncol 2001;1:193-202.
3. Srivastava SC, Dadachova E. Recent advances in radionuclide therapy. Semin Nucl Med 2001;31:330-41.
4. Milenic DE, Brady ED, Brechbiel MW. Antibody-targeted radiation cancer therapy. Nat Rev Drug Discov 2004;3:488-98.
5. Sharkey RM, Goldenberg DM. Perspectives on cancer therapy with radiolabeled monoclonal antibodies. J Nucl Med 2005;46:115S.
6. Rosas AL, Nosanchuk JD, Feldmesser M, Cox GM, McDade HC, Casadevall A. Synthesis of polymerized melanin by Cryptococcus neoformans in infected rodents. Infect Immun 2000;68:2845-53.
7. Dadachova E, Nosanchuk JD, Shi L, et al. Dead cells in melanoma tumors provide abundant antigen for targeted delivery of ionizing radiation by a monoclonal antibody to melanin. Proc Natl Acad Sci U S A 2004; 101:14865-70.
8. Dadachova E, Moadel T, Schweitzer AD, et al. Radiolabeled melanin-binding peptides are safe and effective in treatment of human pigmented melanoma in a mouse model of disease. Cancer Biother Radiopharm 2006;21:117-29.
9. Howell RC, Revskaya E, PazoV, Nosanchuk JD, Casadevall A, Dadachova E. Phage display library derived peptides that bind to human tumor melanin as potential vehicles for targeted radionuclide therapy of metastatic melanoma. Bioconjugate Chem 2007;18:1739-48.
10. Dadachova E, Revskaya E, Sesay MA, et al. Preclinical evaluation and efficacy studies of a melanin- binding IgM antibody labeled with (188)Re against experimental human metastatic melanoma in nude mice. Cancer Biol Ther 2008;7:1116-27.
11. Klein M, Shibli N, Friedmann N,Thornton GB, Chisin R, Lotem M. Imaging of metastatic melanoma (MM) with a 188rhenium (188Re)-labeled melanin binding antibody. J Nucl Med 2008;49:52P.
12. Rosas AL, Nosanchuk JD, Gomez BL, EdensWA, Henson JM, Casadevall A. Isolation and serological analysis of fungal melanins. J Immunol Methods 2000;244:69-80.
13. LindmoT, Boven E, Cuttitta F, et al. Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. J Immunol Methods 1984;72: 77-89.
14. Schweitzer AD, Rakesh V, Revskaya E, Datta A, Casadevall A, Dadachova E. Computational model predicts effective delivery of 188-Re-labeled melanin-binding antibody to the metastatic melanoma tumors with wide range of melanin concentrations. Melanoma Res 2007;17:291 -303.
15. Dadachova E, Casadevall A. Melanin as a potential target for radionuclide therapy of metastatic melanoma. Future Oncol 2005;1:541 -9.
16. Dadachova E, Bryan RA, Apostolidis C, et al. Interaction of radiolabeled antibodies with fungal cells and components of immune system in vitro and during radioimmunotherapy of experimental fungal infection. J Infect Dis 2006;193:1427-36.
17. Seynhaeve ALB,Vermeulen CE, Eggermont AMM, et al. Cytokines and vascular permeability: an in vitro study on human endothelial cells in relation to tumor necrosis factor-α-primed peripheral blood mononuclear cells. Cell Biochem Biophys 2006;44:157-70.
18. Halaschek-Wiener J, KloogY,Wacheck V, Jansen B. Farnesy l thiosalicylic acid chemo-sensitizes human melanoma in vivo. J Invest Dermatol 2003; 120:109-15.
19. Fodstad O, Aass N, Pihl A. Response to chemotherapy of human, malignant melanoma xenografts in athymic, nude mice. Int J Cancer1980;25:453-8.
20. Strobel K, Dummer R, Steinert HC, et al. Chemotherapy response assessment in stage IV melanoma patients-comparison of (18)F-FDG-PET/CT, CT, brain MRI, and tumor marker S-100B. Eur J Nucl Med Mol Imaging 2008 May 6. Epub ahead of print.